menu
    • menu

    Company profile for Sellas Life Sciences Group

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sellas Life Sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. In other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. Our international team of acknowledged scientists, doctor...
    Sellas Life Sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. In other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. Our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of Σellas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sellas Life Sciences GroupUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Times Square Tower, 7 Times Square, Suite 2503, New York, NY 10036
    Telephone
    Telephone
    646-200-5278
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sellaslifesciences.com/Home/default.aspx
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SELLAS Life Sciences Reveals 2025 Financials And Corporate Update
    SELLAS Life Sciences Reveals 2025 Financials And Corporate Update

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259428/0/en/SELLAS-Life-Sciences-Reports-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    SELLAS Life Sciences Showcases Sls009's Strong AML Activity
    SELLAS Life Sciences Showcases Sls009's Strong AML Activity

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257676/0/en/SELLAS-Life-Sciences-to-Present-Preclinical-Data-Highlighting-Potent-Activity-of-SLS009-in-AML-at-the-2026-AACR-Conference.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    SELLAS Enrolls First Patient In New First-Line AML Trial
    SELLAS Enrolls First Patient In New First-Line AML Trial

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254670/0/en/SELLAS-Life-Sciences-Announces-Enrollment-of-First-Patient-in-Newly-Diagnosed-First-Line-AML-Trial-of-SLS009.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    SELLAS Life Sciences Expands SLS009 Clinical Program In Europe
    SELLAS Life Sciences Expands SLS009 Clinical Program In Europe

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218619/0/en/SELLAS-Life-Sciences-Enters-Agreement-with-IMPACT-AML-to-Expand-SLS009-Clinical-Program-into-Europe.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    SELLAS Life Sciences Updates Ph 3 Trial Of Galinpepimut-S in AML
    SELLAS Life Sciences Updates Ph 3 Trial Of Galinpepimut-S in AML

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210926/0/en/SELLAS-Life-Sciences-Provides-Update-on-Pivotal-Phase-3-REGAL-Trial-of-Galinpepimut-S-GPS-in-Acute-Myeloid-Leukemia-AML.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    SELLAS Reveals Positive Phase 2 SLS009+AZA/VEN in R/R AML at ASH
    SELLAS Reveals Positive Phase 2 SLS009+AZA/VEN in R/R AML at ASH

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/07/3201154/0/en/SELLAS-Life-Sciences-Presents-Positive-Phase-2-Data-of-SLS009-in-Combination-with-AZA-VEN-in-Relapsed-Refractory-AML-MR-at-ASH-2025.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search